platinum has been researched along with Hematologic Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Y; Chen, H; Gao, Z; Han, B; Jiang, G; Li, X; Lu, D; Qian, J; Su, B; Tan, X; Wang, J; Wang, S; Wu, Q; Yang, Y; Zhao, X | 1 |
| Atkinson, RJ; Beale, P; Bougnoux, P; Cure, H; Dirix, L; Gore, ME; Rischin, D; Smit, WM; Thomas, H | 1 |
| Blay, P; Buesa, JM; Esteban, E; Estrada, E; Fernández, Y; Fra, J; Lacave, AJ; Mareque, B; Muñiz, I; Palacio, I; Sánchez, R; Uña, E; Vieitez, JM; Villanueva, N | 1 |
| Groshen, S; Jeffers, S; Morris, M; Muderspach, L; Muggia, F; Roman, L; Russell, C; Uziely, B | 1 |
| Christian, MC; den Engelse, L; Gill, I; Grunberg, S; Kortes, V; Michael, C; Muggia, FM; Parker, RJ; Reed, E; Terheggen, PM | 1 |
3 trial(s) available for platinum and Hematologic Diseases
| Article | Year |
|---|---|
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Drug Resistance, Neoplasm; Female; Hematologic Diseases; Humans; Middle Aged; Nausea; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Treatment Failure; Vomiting | 2002 |
Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications.
Topics: Adult; Aged; Bacterial Infections; Disease-Free Survival; Drug Administration Schedule; Drug Resistance; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Paclitaxel; Platinum; Premedication; Risk Factors; Survival Analysis | 1994 |
Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cheek; Cisplatin; DNA; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukocytes; Male; Middle Aged; Mouth Mucosa; Platinum | 1991 |
2 other study(ies) available for platinum and Hematologic Diseases
| Article | Year |
|---|---|
Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; DNA, Neoplasm; Female; Follow-Up Studies; Gastrointestinal Diseases; Genotype; Haplotypes; Hematologic Diseases; Histocompatibility Antigens Class II; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Platinum; Polymorphism, Single Nucleotide; Prognosis | 2014 |
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes.
Topics: Adult; Aged; Camptothecin; Carcinoma, Non-Small-Cell Lung; Confidence Intervals; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Irinotecan; Karnofsky Performance Status; Lung Neoplasms; Male; Middle Aged; Platinum; Prospective Studies; Taxoids | 2003 |